20200120163240wfzc02
20200120163240wfzc02

Gadopentetate Dimeglumine

Product：Gadopentetate Dimeglumine
Indication：Gadolinium-based MRI contrast agent
Specification：In-house
Regulatory status：US, China, Taiwan
BACK BACK